NOVACTA BIOSYSTEMS
Leveraging the extensive knowledge of GSK's Biotransformation and Natural Products scientific team, Novacta Biosystems Ltd was founded in 2003. In the following 5 years, Novacta successfully adopted a dual business model, whereby it developed a biocatalysis and microbial pathway engineering service business, that supported its efforts to build an infectious disease therapeutic pipeline.
NOVACTA BIOSYSTEMS
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Welwyn Garden City, Hertford, United Kingdom
Country:
United Kingdom
Website Url:
http://www.novactabio.com
Total Employee:
51+
Status:
Active
Contact:
441707356131
Email Addresses:
[email protected]
Total Funding:
30.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
Current Advisors List
Current Employees Featured
Investors List
Celtic Pharma
Celtic Pharma investment in Venture Round - Novacta Biosystems
Wellcome Trust
Wellcome Trust investment in Venture Round - Novacta Biosystems
Esperante Ventures
Esperante Ventures investment in Venture Round - Novacta Biosystems
GEIF Ventures
GEIF Ventures investment in Venture Round - Novacta Biosystems
Oxford Technology Management
Oxford Technology Management investment in Venture Round - Novacta Biosystems
Oxford Technology Management
Oxford Technology Management investment in Venture Round - Novacta Biosystems
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Venture Round - Novacta Biosystems
GEIF Ventures
GEIF Ventures investment in Seed Round - Novacta Biosystems
Official Site Inspections
http://www.novactabio.com Semrush global rank: 5.25 M Semrush visits lastest month: 694
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novacta Biosystems"
Home | Novactabio
Biological pathways . Harnessing Biological Systems Novacta Biosystems is a biotechnology company with a proprietary technology platform that harnesses the specificity and efficiency of …See details»
Novacta Biosystems - Crunchbase Company Profile
Organization. Novacta Biosystems . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Login - Novactabio
+1 (408) 472-2934. Sign in; Contact UsSee details»
Novacta Biosystems Ltd. - Drug pipelines, Patents, Clinical trials ...
Www.novactabio.com. Private Company | 2003 | United Kingdom | 50-100 | www.novactabio.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The …See details»
Novacta Biosystems Limited - Welwyn Garden City, United Kingdom
Novactabio.com +441707356130. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. Novacta Biosystems Limited. BioPark Hertfordshire, Broadwater …See details»
Novacta Biosystems - Products, Competitors, Financials, …
Novacta Biosystems Limited Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350. Dec 6, 2016. Novacta Biosystems Limited Mergers Acquisitions …See details»
Novacta Biosystems - VentureRadar
Website: http://www.novactabio.com. Novacta is a drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural ...See details»
Novacta Biosystems Company Profile | Management and
Www.novactabio.com . Novacta Biosystems Profile and History. Novacta is a UK-based biotechnology company that specialises in the discovery and development of potential …See details»
Novacta Biosystems - Overview, News & Similar companies
View Novacta Biosystems (www.novactabio.com) location in Hertfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Novacta - Scientist.com
Novactabio.com: Headquarters: Morrill, VA, US Company Type: Small Business (1-10M TTM Revenue) ... If your organization has a Scientist.com marketplace, you can log in here to order …See details»
Home | NovAdBio
At NovAdBio, we offer a comprehensive range of consulting services to support the development and advancement of new therapeutics. Whether you require drug development strategy …See details»
AutoGen PCR System | Novactabio
AutoGen PCR System - Streamlined Nucleic Acid Purification and Real-Time PCR Automation. Overview: The AutoGen PCR System is a cutting-edge solution designed to automate the …See details»
Novacta Biosystems Ltd. (Novacta Biosystems Ltd.) - 药物管线_专 …
了解Novacta Biosystems Ltd. (Novacta Biosystems Ltd.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试和6篇文献，药物:Nov-203，Nov-206，Nov-204，Nov-209，Nov-208。See details»
Novacta Biosystems Raises £13.1 Million - Venture Capital Journal
Jul 6, 2009 Novacta Biosystems Ltd., a UK-based developer of antibiotics, has raised £ 13.1 million in new VC funding led by Celtic Pharma.The round is payable upon the achievement of …See details»
Novacta Biosystems - PitchBook
Novacta Biosystems General Information Description. Provider of a clinical stage bio-pharmaceutical services intended to treat bacterial infections. The company's clinical stage bio …See details»
Appointment Types | Novactabio
There is currently no appointment available. Novacta Bio . Home; Contact us; Privacy Policy; Help; ForumSee details»
Novacta Biosystems - CB Insights
Solidus Biosciences. Solidus Biosciences is a company that provides business intelligence for the pharmaceutical and biopharmaceutical sectors. Their offerings include market surveillance, …See details»
Espanol | Novactabio
Start Diagnostic kitsPRICES (GBPD) DK0028 ALANINE AMINOTRANSFERASE Method: ultraviolet, kinetic Principle: l-alanine +a-ketoglutarate +ALT = pyruvate +l-glutamate pyruvate …See details»
Novartis receives third FDA approval for oral Fabhalta® (iptacopan ...
2 days ago Novartis receives third FDA approval for oral Fabhalta ® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G). Phase III study showed sustained …See details»
Establishing Canada’s first large-scale bioinnovation centre
3 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»